Scorpion Sting
Conditions
Brief summary
The purpose of this study is to compare the efficiency and safety of the treatment against sting scorpion, using two serums, one elaborated by Birmex versus other commercial serum
Detailed description
We consider relevant conduct this study because the poisoning scorpion bite represents a public health problem. This is a randomized clinical trial, which included 120 subjects of both sexes aged 15 and 60 years old and residents of the state of Guanajuato, divided into 2 groups: 60 patients received antiscorpion serum of Birmex and 60 patients receive other commercial serum.
Interventions
BIOLOGICALserum antiscorpion
The dose may be required for the patient according to clinical manifestations and evolution
Sponsors
Laboratorios de Biologicos y Reactivos de México, S.A. de C.V.
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
15 Years to 60 Years
Healthy volunteers
No
Inclusion criteria
* Sting scorpion * Informed consent * Age 15-60 * Either sex * Resident in study area
Exclusion criteria
* Previous treatment with gammaglobulin * Blood transfusion at any stage of life * Sensitivity or intolerance to serums antiscorpion or horse products * Pregnancy * Some immunodeficiency
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Resolution of signs and symptoms of scorpion envenomation | after treatment (expected average of 12 hrs) |
Secondary
| Measure | Time frame |
|---|---|
| Evaluate the adverse events in every treated child | inmediately after treatment and until 5 days later |
Outcome results
None listed